Browse
Submit Data
Databases
API
Help

Dataset Information

6 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Correction: Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.

ABSTRACT: [This corrects the article DOI: 10.1371/journal.pone.0244995.].

SUBMITTER: Baral R

PROVIDER: S-EPMC8061918 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.

Project description: Not available

| S-EPMC7799756 | biostudies-literature

The Costs of Implementing Vaccination With the RTS,S Malaria Vaccine in Five Sub-Saharan African Countries.

Project description: Not available

| S-EPMC6923697 | biostudies-literature

Gene expression profiling after vaccination with the RTS,S candidate malaria vaccine in a controlled human malaria infection study

Project description:RTS,S is the sole candidate vaccine shown to provide protection against infection to malaria-naive adults challenged with mosquito-borne homologous falciparum malaria and protection against infection and clinical and severe disease to volunteers in malaria-endemic Africa who were exposed to diverse Plasmodium falciparum strains. In this experiment we profiled gene expression in PBMCs after vaccination with the RTS,S candidate malaria vaccine in a controlled human malaria infection study. Subjects were vaccinated with three doses of the RTS,S candidate malaria vaccine. Blood samples for PBMC isolation and subsequent gene expression analysis were taken on day 0 (0m), day of the third vaccination (8w), 1 day post third vaccination (8w1d), 3 days post third vaccination (8w3d), the day of the infection (10w), 1 day post infection (10w1d), and 5 days post infection (10w5d). After infection the subjects were closely monitored for parasitemia. The response to the controlled infection was recorded as follows: no parasitemia (P, protected), parasitemia in the same time frame as the control group (NP, not protected), parasitemia later than the control group (DL, delayed). In addition to the experimental factors, a confounding factor was identified in the data analysis related to the use of a specific kit batch (Kit A or B).

2017-04-27 | E-MTAB-4629 | biostudies-arrayexpress

[The RTS,S/AS01 malaria vaccine in children aged 5-17 months at first vaccination].

Project description: Not available

| S-EPMC6201624 | biostudies-literature

Gene responses to RTS,S malaria vaccination in controlled human malaria study

Project description:Identification of gene signatures that are associated with protection in RTS,S malaria vaccination study

2020-04-21 | GSE102288 | GEO

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention.

Project description: Not available

| S-EPMC7493088 | biostudies-literature

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries.

Project description: Not available

| S-EPMC6906355 | biostudies-literature

Systems analysis of protective immune responses to RTS,S malaria vaccination in humans

Project description:We applied a systems biology approach to study immune responses in subjects receiving 3 consecutive immunizations with RTS,S/AS01 (RRR), or in those receiving 2 immunizations of RTS,S/AS01, following a primary immunization with adenoviral Ad35 (ARR) vector expressing circumsporozoite protein.

2017-03-01 | GSE89292 | GEO

Transcriptional responses to RTS,S induced vaccination in controlled human malaria infection studies

Project description:Identification of host responses that are induced by RTS,S vaccination in controlled malaria infection

2020-04-21 | GSE107672 | GEO

Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.

Project description: Not available

| S-EPMC5338562 | biostudies-literature